Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: Clinical characteristics and outcomes

Aristolochic acid-associated urothelial cancer in Taiwan

(2012) C.-H. Chen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Impact of Tumor Multifocality on Outcomes in Patients Treated With Radical Nephroureterectomy

(2011) Thomas F. Chromecki et al.   EUROPEAN UROLOGY

TP53 Mutational signature for aristolochic acid: an environmental carcinogen

(2011) Masaaki Moriya et al.   INTERNATIONAL JOURNAL OF CANCER

Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid

(2011) Bojan Jelaković et al.   KIDNEY INTERNATIONAL

Risks of Kidney Failure Associated With Consumption of Herbal Products Containing Mu Tong or Fangchi: A Population-Based Case-Control Study

(2010) Ming-Nan Lai et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973-2005

(2010) Jay D. Raman et al.   BJU INTERNATIONAL

Population-Based Case-Control Study of Chinese Herbal Products Containing Aristolochic Acid and Urinary Tract Cancer Risk

(2009) M.-N. Lai et al.   JNCI-Journal of the National Cancer Institute

Clinicopathological Characteristics and Survival Outcome of Arsenic Related Bladder Cancer in Taiwan

(2008) Chung-Hsin Chen et al.   JOURNAL OF UROLOGY

Prescription profile of potentially aristolochic acid containing Chinese herbal products: an analysis of National Health Insurance data in Taiwan between 1997 and 2003

(2008) Shu-Ching Hsieh et al.   Chinese Medicine